|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500100754 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-15 09:45:12 |
|
注册时间: Date of Registration: |
2025-04-15 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
不同肥胖表型人群心肌做功及与心外膜脂肪组织相关性研究 |
|
Public title: |
A Study on Myocardial Work and Its Correlation with Epicardial Adipose Tissue in Different Obesity Phenotypes |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同肥胖表型人群心肌做功及与心外膜脂肪组织相关性研究 |
|
Scientific title: |
A Study on Myocardial Work and Its Correlation with Epicardial Adipose Tissue in Different Obesity Phenotypes |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
吕卓欣 |
研究负责人: |
耿登峰 |
|
Applicant: |
Lyu zx |
Study leader: |
Geng df |
|
申请注册联系人电话: Applicant telephone: |
+86 155 5139 4919 |
研究负责人电话: Study leader's telephone: |
+86 136 6899 3046 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
826694045@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
dr.dfengg@hotmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广州市越秀区沿江西路107号 |
研究负责人通讯地址: |
广州市越秀区沿江西路107号 |
|
Applicant address: |
No. 107 Yanjiang West Road, Yuexiu District, Guangzhou |
Study leader's address: |
No. 107 Yanjiang West Road, Yuexiu District, Guangzhou |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中山大学孙逸仙纪念医院 |
||
|
Applicant's institution: |
Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
||
|
研究负责人所在单位: |
中山大学孙逸仙纪念医院 |
||
|
Affiliation of the Leader: |
Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
SYSKY-2025-283-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中山大学孙逸仙纪念医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-04-10 00:00:00 |
||
|
伦理委员会联系人: |
区柳珊、彭珊小 |
||
|
Contact Name of the ethic committee: |
Ou ls, Peng sx |
||
|
伦理委员会联系地址: |
广州市越秀区长堤大马路171-181 号一方长堤7 楼715 |
||
|
Contact Address of the ethic committee: |
Room 715, Floor 7, One Fang Changdi, No. 171-181 Changdi Main Road, Yuexiu District, Guangzhou |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 20 8133 2587 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中山大学孙逸仙纪念医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中山大学孙逸仙纪念医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
None |
||||||||||||||||||||||
|
Target disease: |
obesity |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
本研究旨在应用整体心肌做功指标,分析不同肥胖表型人群(MHO、MUNW、MUO)心脏功能的受损情况,评估不同肥胖亚型与亚临床心功能不全的关系。探究心外膜脂肪组织体积是否直接或间接与心肌做功指标相关。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to apply global myocardial work indices to analyze the impairment of cardiac function in individuals with different obesity phenotypes (MHO, MUNW, MUO), and to evaluate the relationship between different obesity subtypes and subclinical cardiac dysfunction. It also explores whether the volume of epicardial adipose tissue is directly or indirectly correlated with myocardial work indices. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 本研究纳入 2024 年 5 月-2025 年 3 月在我院因体检或稳定性胸痛门诊就诊或住院, 同时行心脏超声检查、 冠状动脉 CTA 检查及相关心肌酶学、 生化等抽血检查者; 2. 既往无心力衰竭病史, 即不符合《中国心力衰竭诊断和治疗指南 2024》 中相关心衰诊断标准者。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. This study includes patients who were admitted to the outpatient clinic or hospitalization for physical examination or stable chest pain in our hospital from May 2024 to March 2025, and underwent cardiac ultrasound, coronary CTA and related cardiac enzymes, biochemistry and other blood draws; 2. Those who have no previous history of heart failure, that is, those who do not meet the relevant diagnostic criteria for heart failure in the Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024. |
||||||||||||||||||||||
|
排除标准: |
1.患有心肌病、 心脏瓣膜病等心脏器质性病变者; 2.患有房颤、 完全性束支传导阻滞及严重心律失常者; 3.近 6 个月内有急性冠脉综合征或行 PCI/CABG 手术者; 4.存在明显贫血、 肝病、 动静脉瘘等高输出量疾病; 5.肾能明显异常, eGFR<30 L/min 者; 6.恶性肿瘤及肿瘤相关治疗后患者; 7.过于肥胖, BMI>40 者; 8.图像质量差无法分辨者或重要病例资料缺失者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with cardiomyopathy, heart valve disease and other organic cardiac lesions; 2. Patients with atrial fibrillation, complete bundle branch block and severe arrhythmia; 3. Those who have acute coronary syndrome or PCI/CABG surgery in the past 6 months; 4. Presence of obvious anemia, liver disease, arteriovenous fistula and other high-output diseases; 5. Patients with obvious abnormal renal energy, eGFR<30 L/min; 6. Patients with malignant tumors and tumor-related treatments; 7. Those who are overweight and have a BMI > 40; 8. Those who have poor image quality and cannot be distinguished or those who lack important case data. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-04-15 00:00:00至 To 2025-05-15 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-04-15 00:00:00 至 To 2025-05-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
无 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
None |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |